Therasense, Inc. v. Becton, Dickinson and Company, No. 12-1504 (Fed. Cir. Mar. 12, 2014)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Becton, Dickinson and Company (Becton) and Nova Biomedical Corporation (Nova) appeal the denial of var i- ous fees sought based on an eight-year long patent in- fringement suit in the United States District Court for the Northern District of California involving patents owned by Therasense, Inc. (now known as Abbott Diabetes Care, Inc.) and Abbott Laboratories (collectively , Abbott).